Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2026-05-11 18:52:09 ET · period of report 2026-05-11 · accession 0001437749-26-016188 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 18:52 | 2026-05-11 | PLSE | DUGGAN ROBERT W | Dir, 10% | P - Purchase | $19.69 | +660.2K | 48.21M | +1% | +$13.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | P | A | 660,233 | $19.69 | 48,211,433 | D | — | — | (F1) The shares reported herein were acquired through the Company's at-the-market equity offering program established pursuant to that certain Equity Distribution Agreement, dated February 19, 2026, by and between the Company and TD Securities (USA) LLC, as sales agent. The shares were purchased during an open trading window under the Company's Insider Trading Policy and in accordance with applicable securities laws. (F2) The shares reported herein were acquired through the Company's at-the-market equity offering program at the prevailing market bid price or better at the time of sale. |